John Nash joins BioFocus as Senior Director, ADME/PK
News Oct 01, 2009
John has 30 years industrial experience with both service and major pharmaceutical companies. Most recently, John worked for eight years for Charles River Laboratories in Quebec, Canada, where he was responsible for strengthening the DMPK service business, and making it a successful, revenue generating operation. Prior to moving to Canada, John worked in the UK with Anserve and AstraZeneca/Syngenta in metabolism and pharmacokinetics. John holds an M. Phil. degree from the University of Surrey and a Ph. D. degree from the University of Manchester.
“John Nash’s appointment is a major win for BioFocus in the UK,” commented Dr. Chris Newton, SVP BioFocus. “With this hire, BioFocus continues to elevate its 175 scientist facility at Chesterford Research Park into a leading integrated discovery research center for pharma, biotech and not-for-profit organizations worldwide.”
For further information, please visit www.biofocus.com.
A new experimental system has been designed that can rapidly assess the pathogenic effects of a drug on a baby's developing brain. The system uses embryonic stem cells reprogrammed into neurons, and offers a powerful tool for probing genetic and molecular underpinnings of drug-induced neurodevelopmental disorders.READ MORE
An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.READ MORE